Max Shi is a postdoctoral fellow working at Chinese University of Hong Kong. Her current research interest focuses on using multi-omics to decipher immune-epithelium interaction in chronic pulmonary disease. Her work also involves establishing scalable and ready-to-use disease-conditioned organoids for drug screening and personalised medicine.